NBP Sale Disclosure
Xu Cong Claire · SEC Form 4 · Filed Sep 1, 2026
Sale
Calculated transaction value
$2.59K
Xu Cong Claire EVP, Clinical Development
NBP
Transaction date
Aug 31, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed 1 day later
NBP daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 3,282 shares @ $0.79
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002114309-26-000007
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$2.59K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Novabridge Biosciences NBP Current | Sale | Aug 31, 2026 | $2.59K |
| Novabridge Biosciences NBP | Exercise | Aug 30, 2026 | Not reported |
| Novabridge Biosciences NBP | Exercise | Aug 30, 2026 | $0 |